微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力，但也强烈抑制Flk-1和FGFR1反磷酸化，对IGF-1R，Met，Src， Lck，Zap70，Abl和CDK2； 不抑制EGFR。
靶点信息
| PDGFRβ (Cell-free assay) | FGFR1 (Cell-free assay) | Flk1 (Cell-free assay) | ||
| 8 nM(Ki) | 1.2 μM(Ki) | 2.1 μM(Ki) |
| In vitro (25°C) | DMSO | 55 mg/mL (177.22 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 32.22 mL | 161.08 mL | 322.16 mL |
| 0.5 mM | 6.44 mL | 32.22 mL | 64.43 mL |
| 1 mM | 3.22 mL | 16.11 mL | 32.22 mL |
| 5 mM | 0.64 mL | 3.22 mL | 6.44 mL |
*The above data is based on the productmolecular weight 310.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10953 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 310.4 |
| Formula | C18H18N2O3 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 252916-29-3 |
| Synonyms | TSU68 |
| SMILES | CC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O |
产品资料
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，可控制或正常化VEGFR-2，同时抑制B-raf和c-Raf…
E7080 (Lenvatinib)
E7080 (Lenvatinib)是一种多激酶抑制剂，可同时抑制VEGFR2和VEGFR3激酶。
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂，可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
ZM 306416
ZM 306416 hydrochloride是一种VEGF受体酪氨酸激酶抑制剂，可抑制KDR（IC50 = 100 nM）和Flt（IC50 = 2 uM）酪氨酸激酶…
NVP-BAW2881
NVP-BAW2881是有效的选择性VEGFR抑制剂（血管内皮生长因子受体酪氨酸激酶抑制剂），IC50 为值9 nM，具有抑制…
XL184 free base (Cabozantinib)
XL184 free base (Cabozantinib)是设计用来抑制多种受体酪氨酸激酶（特别是MET和VEGFR2）的小分子。
Keywords:购买 TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) 供应商 | 订购 TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) 价格 | TSU-68 (Orantinib, SU6668) 生产商 | 订单 TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) 代理商 | 购买 252916-29-3| 252916-29-3 供应商 | 订购 252916-29-3 | 252916-29-3 价格 | 252916-29-3 生产商 | 订单 252916-29-3 | 252916-29-3 代理商|buy TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) Supplier | purchase TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) cost | TSU-68 (Orantinib, SU6668) manufacturer | order TSU-68 (Orantinib, SU6668) | TSU-68 (Orantinib, SU6668) distributor | buy 252916-29-3| 252916-29-3 Supplier | purchase 252916-29-3 | 252916-29-3 cost | 252916-29-3 manufacturer | order 252916-29-3 | 252916-29-3 distributor